Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Clinical Oncology School of Fujian Medical University

1 abstract

Abstract
Open-label, phase 2 study of adebrelimab combined with fuzuloparib in the treatment of patients with HRD-positive, recurrent platinum-resistant ovarian cancer.
Org: Clinical Oncology School of Fujian Medical University,